secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2022-11-01T23:59:59+00:00
Accession:  0001193125-22-274553
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edwards Lifesciences announces $750M accelerated share repurchase, initial ~8M shares
--------------------------------------------------------------------------------

- $750M ASR executed; initial delivery of ~8M shares, remainder based on VWAP over term.
- Total 2022 repurchases exceed $1.7 billion.
- Approximately $900 million remains in board-authorized repurchase plan.
- Repurchase funded with existing cash.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000119312522274553/0001193125-22-274553-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000119312522274553/d414194d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-274553

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer